Skip to main content

Table 2 Sedation choices by continent before the COVID-19 pandemic

From: Practices in sedation, analgesia, mobilization, delirium, and sleep deprivation in adult intensive care units (SAMDS-ICU): an international survey before and during the COVID-19 pandemic

Variables
n
Asia
169 (%)
Europe
408 (%)
South America
739 (%)
Drugs usually used for sedation
 Midazolama 65.1 80.9 92.3
 Lorazepama 10.1 4.4 16.6
 Haloperidolb 20.7 20.3 28.3
 Morphinea 45.6 17.2 17.6
 Fentanyla 77.5 19.1 53.6
 Propofola 50.9 91.9 78.1
 Remifentanila 0.6 27.9 6.1
 Dexmedetomidinea 64.5 61.00 67.9
 Ketaminea 5.9 25.7 34.2
 Quetiapinea 14.2 8.3 29.2
Sedative drugs used for sedation in patients with septic shock
 Midazolama 34.9 64.6 69.1
 Lorazepam 3 0.7 2.7
 Haloperidolb 4.1 0.7 3.9
 Morphinea 32.5 11.8 7
 Fentanyla 79.9 25 66.1
 Propofola 6.5 46.6 44.7
 Remifentanila 0.59 20.3 10.2
 Dexmedetomidinea 20.1 12 30.9
 Ketaminea 8.3 16.2 32
 Quetiapineb 2.4 0.3 4.2
Sedative drugs used for sedation in patients with ARDS
 Midazolama 49.7 66.7 80.4
 Lorazepamb 0.6 0.3 4
 Haloperidol 2.4 1 3
 Morphinea 39 14.5 10
 Fentanyla 82.3 29.9 73
 Propofola 22.5 67.2 65.6
 Remifentanila 0 21.6 10.26
 Dexmedetomidinea 35.5 11.8 26.1
 Ketaminea 2.4 16.4 30.9
 Quetiapine 3.6 0.5 3.9
Sedative drugs used for sedation in agitated patients under noninvasive ventilation
 Midazolamb 20.1 13.7 8.9
 Lorazepam 5.3 5.9 8.1
 Haloperidolb 23.7 35.3 34
 Morphineb 13.6 14.5 23.7
 Fentanyla 32 6.1 14.9
 Propofola 3 25.5 10.8
 Remifentanila 1.8 9.6 3.7
 Dexmedetomidinea 38.5 55.9 75.5
 Ketaminea 0.6 7.4 16.6
 Quetiapinea 13 10.3 31.7
  1. a p < 0.001; bp < 0.05; cARDS, acute respiratory distress syndrome
  2. Italic emphasis are the most frequent choice in each context